The Use of Mechlorethamine, Cyclophosphamide, And Uracil Mustard in Neoplastic Disease: A Cooperative Study
- 4 March 1970
- journal article
- clinical trial
- Published by Wiley in The Journal of Clinical Pharmacology and The Journal of New Drugs
- Vol. 10 (2), 110-120
- https://doi.org/10.1177/009127007001000206
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- EFFECTS OF SELECTED CYTOTOXIC AGENTS ON ANTIBODY PRODUCTION IN MAN; A PRELIMINARY REPORT*Annals of the New York Academy of Sciences, 1964
- Uracil Mustard, a New Alkylating Agent for Oral Administration in the Management of Patients with Leukemia and LymphomaNew England Journal of Medicine, 1961
- Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramideJournal of Chronic Diseases, 1960
- Chemotherapeutic Action of a Cyclic Nitrogen Mustard Phosphamide Ester (B 518-ASTA) in Experimental Tumours of the RatNature, 1958
- The Catalysis of the H2-D2O Exchange by Aqueous Buffer Solutions1Journal of the American Chemical Society, 1958
- NITROGEN MUSTARD THERAPYJAMA, 1946
- NITROGEN MUSTARDS IN THE TREATMENT OF NEOPLASTIC DISEASEJAMA, 1946
- The Biological Actions and Therapeutic Applications of the B-Chloroethyl Amines and SulfidesScience, 1946